Factual side-by-side: what each tool does, where each is strong, and where each is thin. ZoomInfo is positioned as b2b contact intelligence and sales-engagement platform. Distrolens is positioned as named distributor intelligence for 21 emerging markets (Nigeria, Saudi Arabia, UAE, Kenya, and 17 more), sourced from regulator registries.
ZoomInfo aggregates B2B contact data from web crawling, contributory data networks, and public records. Core product is sales prospecting: company search, contact discovery, email + phone enrichment, intent signals.
Pharma distribution intelligence: named distributors across 21 emerging markets, sourced from regulator registries (NAFDAC, SFDA, MOHAP, SAHPRA, EudraGMDP, TED). Verified contact emails, supply-chain edges, sanctions screening (14-day half-life), and live Chao1 coverage published per country including where we are weak.
4 dimensions. Claims are factual and citable — sourced from ZoomInfo’s own public materials and Distrolens production data. No marketing puffery either way.
Generic B2B contact data — pharma distributors appear, but no regulator-license context, no drug-registration history, no supply-chain edges
Every distributor traced to regulator registrations (NAFDAC, SFDA, MOHAP, SAHPRA, EudraGMDP), with brand portfolios + compliance status
Strong US/EU, thin in Sub-Saharan Africa, GCC, South Asia for pharma-specific entities
Pharma-specific from day one in 21 EM countries, sourced from local regulator portals
ZoomInfo Re-verification frequency and bounce-rate methodology aren't published per record
Per-dimension half-life decay (EMAIL 30-day, LICENSE 90-day, SANCTIONS 14-day). ZeroBounce + Reoon waterfall on every export. Customer-facing freshness signal
Industry classification (SIC/NAICS) but no per-jurisdiction regulator-license linkage
Each company carries its regulator licenses + expiration dates — actionable for due-diligence and compliance teams
Tiered seat-based pricing — typical $15K-50K/yr for SalesOS depending on seats + add-ons
Contract: Annual contracts, multi-seat licensing.
Source: Public ZoomInfo pricing page + analyst coverage (NASDAQ:ZI), exact figures under NDA
$500/country/month List · $1,200/country/month Intel · bundle discounts −15% / −25% / −30% at 3 / 6 / 10+ countries.
Contract: month-to-month, no minimum, cancel any month.
20-minute discovery call required before CSV + REST API access.
You're a generic B2B sales team prospecting across many industries in US/Western Europe and need wide breadth.
You're a pharma or medtech brand owner needing distributor partners in emerging markets where ZoomInfo coverage is thin and pharma-specific context matters.